Mon, September 30, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 20, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 10, 2024
Fri, April 5, 2024
Tue, March 5, 2024
[ 12:00 AM ] - WOPRAI
Mon, February 5, 2024
Fri, January 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 13, 2022
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 3, 2022
[ 12:00 AM ] - WOPRAI
Wed, October 19, 2022
[ 12:00 AM ] - WOPRAI
Wed, September 14, 2022
Thu, May 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, March 23, 2022
[ 12:00 AM ] - WOPRAI
Fri, March 11, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 1, 2022
[ 12:00 AM ] - WOPRAI
Wed, February 16, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, January 31, 2022
[ 12:00 AM ] - WOPRAI
Fri, January 7, 2022
[ 12:00 AM ] - WOPRAI
Fri, December 31, 2021
[ 12:00 AM ] - WOPRAI
Thu, November 18, 2021
[ 12:00 AM ] - WOPRAI
Wed, November 17, 2021
Wed, October 20, 2021
[ 12:00 AM ] - WOPRAI
Thu, September 9, 2021
Roanna Ruiz Reiterated (AQST) at Buy with Increased Target to $12 on, Sep 30th, 2024
Roanna Ruiz of Leerink Partners, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy with Increased Target from $10 to $12 on, Sep 30th, 2024.
Roanna, nor any peers, have made any analyst calls on AQST in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources